A recent NHS study spanning 10 years indicates that focal therapy for prostate cancer is as effective as traditional treatments like surgery and radiotherapy, but with significantly lower side effects. The study involved nearly 3,500 men, revealing that only two had died from the disease a decade after treatment, while many avoided complications such as incontinence and sexual dysfunction.
The study's findings could prompt a shift in treatment protocols, pushing for broader access to focal therapy. Watch for NICE's response and potential policy changes that may expand treatment options for prostate cancer, improving patient outcomes nationwide.